Spyre Therapeutics, Inc.

MANUFACTURERS LIFE INSURANCE COMPANY, THE SYRE

Report date

3/31/2022

Quarter

2022 Q1

Filed

8/11/2023

11,679

Value ($000)

Weight

0.0%

2019 Q4 - 2022 Q1 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	8/11/2023	27	0.0%	11,679	3/31/2022
2021 Q4	2/16/2022	96	0.0%	20,139	12/31/2021
2021 Q3	11/12/2021	201	0.0%	25,323	9/30/2021
2021 Q2	8/12/2021	185	0.0%	26,523	6/30/2021
2021 Q1	5/3/2021	230	0.0%	29,097	3/31/2021
2020 Q4	2/12/2021	229	0.0%	29,124	12/31/2020
2020 Q3	11/9/2020	183	0.0%	25,754	9/30/2020
2020 Q2	8/10/2020	236	0.0%	25,754	6/30/2020
2020 Q1	5/15/2020	87	0.0%	18,583	3/31/2020
2019 Q4	2/14/2020	133	0.0%	17,398	12/31/2019